The ROE as of September 2024 (TTM) for LAVA Therapeutics N.V. (LVTX) is -48.53%

According to LAVA Therapeutics N.V.’s latest financial reports and current stock price. The company's current ROE is -48.53%. This represents a change of 293.60% compared to the average of -12.33% of the last 4 quarters.

LAVA Therapeutics N.V. (LVTX) Historical ROE (quarterly & annually)

How has LVTX ROE performed in the past?

The mean historical ROE of LAVA Therapeutics N.V. over the last ten years is -108.70%. The current -48.53% ROE has changed -55.35% with respect to the historical average. Over the past ten years (40 quarters), LVTX's ROE was at its highest in in the June 2020 quarter at 231.40%. The ROE was at its lowest in in the March 2019 quarter at -167.97%.

LAVA Therapeutics N.V. (LVTX) ROE by Quarter and Year

Discovering the peaks and valleys of LAVA Therapeutics N.V. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

LAVA Therapeutics N.V. (LVTX) Average ROE

How has LVTX ROE performed in the past?

The current ROE of LAVA Therapeutics N.V. (LVTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

LAVA Therapeutics N.V. (LVTX) ROE vs. Peers

How is LVTX’s ROE compared to its peers?

LAVA Therapeutics N.V.’s ROE is greater than Anebulo Pharmaceuticals, Inc. (-122.97%), greater than PMV Pharmaceuticals, Inc. (-21.96%), greater than Miromatrix Medical Inc. (-119.21%), less than ZIVO Bioscience, Inc. (673.84%), greater than Bionomics Limited (-150.24%), greater than Edgewise Therapeutics, Inc. (-28.01%), greater than Ikena Oncology, Inc. (-42.81%), greater than Design Therapeutics, Inc. (-18.48%), greater than Xilio Therapeutics, Inc. (-176.51%), greater than Eliem Therapeutics, Inc. (-47.03%), greater than Aerovate Therapeutics, Inc. (-83.65%), greater than Adagene Inc. (-63.48%), greater than Acrivon Therapeutics, Inc. Common Stock (-47.31%), greater than Rezolute, Inc. (-60.90%), greater than AN2 Therapeutics, Inc. (-54.72%), greater than Generation Bio Co. (-92.86%), greater than Kronos Bio, Inc. (-68.82%), greater than Erasca, Inc. (-131.94%), greater than C4 Therapeutics, Inc. (-44.60%), greater than Neoleukin Therapeutics, Inc. (-47.64%), greater than Instil Bio, Inc. (-55.57%), greater than Achilles Therapeutics plc (-47.36%), greater than NextCure, Inc. (-57.63%), greater than Assembly Biosciences, Inc. (-121.55%),

Build a custom stock screener for LAVA Therapeutics N.V. (LVTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like LAVA Therapeutics N.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

LAVA Therapeutics N.V. (LVTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like LAVA Therapeutics N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.